Merck

World & Business

CNBC reports Keytruda Qlex brought in $830 million in quarterly sales, topping the $649 million StreetAccount estimate.

BA

CN

TC

5 Sources, 2h ago, first seen 2h ago

Science

Medical Xpress reports 41% lower progression risk versus chemotherapy in women previously treated with chemotherapy and immunotherapy.

ST

PH

CL

6 Sources, 2d ago, updated 2d ago

Science

Intismeran autogene targets mutations unique to each patient's tumor, STAT reports.

TP

ST

JI

64 Sources, 4h ago, updated 4h ago

Science

STAT News says Moderna's Stephen Hoge discussed the Merck partnership behind an mRNA cancer vaccine at the STAT Summit.

ST

2 Sources, 13d ago, first seen 13d ago

Science

STAT describes Recarbio as an important antibiotic in the US and reports that Merck discontinued it despite concerns over resistance to superbugs.

ST

2 Sources, 29d ago, updated 29d ago